Medtech startup SigTuple has raised Rs 33 crore ($4 million) in its extended Series C round led by SIDBI Venture Capital, with participation from existing investors including Endiya Partners, and a few strategic leaders from the healthcare sector.
Previously, the Bengaluru-based company had raised $4.3 Mn in its Series C round led by Endiya Partners and Accel in March 2023. The firm has raised over $40 million to date.
The new proceeds will be used to drive geographical expansion, expand its product portfolio and support regulatory clearances, SigTuple said in a press release.
Founded in 2015 by Apurv Anand, Bharath Cheluvaraju, Rohit Kumar Pandey and Tathagato Dastidar, SigTuple makes AI-driven smart robotic microscopes to automate the manual process in clinical laboratories.
Since 2020, SigTuple has focused on its core product, AI100, which is now gaining significant traction in the Indian market with major diagnostics industry players as customers.
Partnering with Horiba Medical as its South Asia distribution channel, SigTuple has also expanded into Southeast Asia, the Middle East, and North Africa, and plans to enter Europe and the Americas. In September 2023, AI100 received US FDA 510(k) approval, making SigTuple the third company globally—and the first in India—to achieve this for AI-assisted digital haematology.